Tumor necrosis factor (TNF) receptor associated factor 1 gene (TRAF1) overexpression in B-cell chronic lymphocytic leukemia (B-CLL).

被引：0
|
作者：
Munzert, GM
Kirchner, D
Stobbe, H
Bergmann, L
Schmid, RM
Döhner, H
Heimpel, H
机构：
[1] Univ Ulm, Dept Hematol Oncol, Ulm, Germany
[2] Univ Ulm, Dept Gastroenterol, Ulm, Germany
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1593
引用
收藏
页码：369A / 369A
页数：1
相关论文
共 50 条
  • [31] Plasma levels of vascular endothelial growth factor (VEGF) are predictive of disease-progression in B-cell chronic lymphocytic leukemia (B-CLL).
    Maurillo, L
    Del Poeta, G
    Venditti, A
    Giovanna, S
    Buccisano, F
    Del Principe, MI
    Tamburini, A
    Scornajenghi, A
    Epiceno, AM
    Piccioni, D
    Amadori, S
    BLOOD, 2001, 98 (11) : 360A - 360A
  • [32] Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
    Del Poeta, G.
    Del Principe, M., I
    Luciano, F.
    Maurillo, L.
    Buccisano, F.
    Gattei, V
    Niscola, P.
    Venditti, A.
    Imo Consalvo, M.
    Catalano, G.
    de Fabritiis, P.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [33] A CASE OF CLASSICAL KAPOSIS-SARCOMA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    CONTU, L
    CARCASSI, C
    LANASA, G
    ZURRIDA, SM
    SIRIGU, F
    DELGIACCO, S
    CERIMELE, D
    LONGINOTTI, M
    PITZUS, F
    TUMORI, 1986, 72 (04) : 365 - 374
  • [34] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [35] GENETIC PREDISPOSITION OF AUTOIMMUNE-DISEASE AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    SHIRAI, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 173 (01): : 133 - 140
  • [36] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    Blonski, JZ
    Kasznicki, M
    Gora-Tybor, J
    Konopka, L
    Dmoszynska, A
    Skotnicki, AB
    Stella-Holowiecka, B
    Kuliczkowski, K
    Dwilewicz-Trojaczek, J
    BLOOD, 2000, 96 (11) : 293B - 293B
  • [37] Consolidation with rituximab improves outcome in high risk B-cell chronic lymphocytic leukemia (B-CLL)
    Del, Poeta G.
    Del, Principe M., I
    Maurillo, L.
    Buccisano, F.
    Niscola, F.
    Catalano, G.
    Venditti, A.
    Gattei, V
    Perrotti, A. P.
    de Fabritiis, F.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 23 - 23
  • [38] CONTROL OF B-LYMPHOCYTE PROLIFERATION BY TRANSFORMING GROWTH-FACTOR-BETA (TGF-B) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    LAGNEAUX, L
    DELFORGE, A
    BRON, D
    STRYCKMANS, P
    BLOOD, 1994, 84 (10) : A526 - A526
  • [39] Induction of TNF receptor associated factor 1 (TRAF1) in hyperoxia exposed murine lung
    Pryhuber, GS
    Huyck, HL
    FASEB JOURNAL, 2001, 15 (04): : A162 - A162
  • [40] The chemokine receptor CXCR-4 is consistently expressed and functionally active in B-cell chronic lymphocytic leukemia (B-CLL)
    Möhle, R
    Faileschmid, C
    Bautz, F
    Kanz, L
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 110 - 110
12345